|
|
 |
|
Viewing report
|
|
|
|
Germany Nephrology Biomarkers - A Market Snapshot
GlobalData, June 2011, Pages: 7
“Germany Nephrology Biomarkers - A Market Snapshot” provides key information and analysis on the nephrology biomarkers market in Germany. The report provides information on the applications of different biomarkers in the diagnosis of renal failure and monitoring of patients post transplant. The report analyses the market size and volume of key biomarkers such as Serum Creatinine (SCr) and Neutrophil Gelatinase Associated Lipocalin (NGAL) in Germany.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Scope
- Applications of Biomarkers in the Diagnosis of Kidney Conditions such as Acute Renal Failure and Chronic Kidney Disease.
- Analysis and Comparison of Various Nephrology Biomarkers currently used by physicians.
- Market Sizing and Volumes of Key Nephrology Biomarkers in Germany for the year 2010.
- Key Information on Major Players with Neutrophil Gelatinase Associated Lipocalin (NGAL)-based immunoassays.
- Insights on Possible Trends in the Nephrology Biomarker market due to the demand for early detection of renal failure.
Reasons to buy
- Develop business strategies by understanding the opportunities and unmet needs in the German Nephrology Biomarker market.
- Understand and invest in key enhancements to technology to meet potential client needs in diagnosis of renal failures.
- Design and develop your marketing and sales strategies
- Develop market expansion strategies.
- Exploit M&A opportunities by identifying key areas of growth.
|
|
|
|
